Drug profile · INN
dexrazoxane
SAVENE
dexrazoxane (SAVENE) is a dna topoisomerase ii inhibitor.
EMA: approved Various (V03) V03AF02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — dexrazoxane
- Class
- Various (V03)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
dexrazoxane (SAVENE) is a dna topoisomerase ii inhibitor.
Key facts
INN dexrazoxane
Brand SAVENE
Mechanism DNA topoisomerase II inhibitor
Target DNA topoisomerase II
Therapeutic class Various (V03)
ATC code V03AF02
Mechanism of action
DNA topoisomerase II inhibitor
Primary target: DNA topoisomerase II
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dexrazoxane?
dexrazoxane (SAVENE) is a dna topoisomerase ii inhibitor.
What is the brand name for dexrazoxane?
SAVENE is a marketed brand name for dexrazoxane. Check FDA Drugs@FDA for the current US label holder and prescribing information.